In vitro and in vivo effects of rifampin on Staphylococcus epidermidis graff infections

ASAIO Journal

Volumn 43, Issue 1, 1997, Pages 8-12

  Garrison Jr , James R ^a   Henke, Peter K ^a   Smith, Kenneth R ^a   Brittian, Kenneth R ^a   Lam, Tina M ^a   Peyton, James C ^a   Bergamini, Thomas M ^a,b  

^a UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE   (United States)

^b University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTICS; BACTERIA; IMPLANTS (SURGICAL); LIVING SYSTEMS STUDIES; PHYSIOLOGICAL MODELS; PROSTHETICS;

RIFAMPIN;

GRAFTS;

RIFAMPICIN; VANCOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BLOOD VESSEL GRAFT; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESISTANCE; GRAFT INFECTION; IN VITRO STUDY; IN VIVO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; RAT; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS INFECTION;

EID: 0343924368     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002480-199743010-00003     Document Type: Article

References (33)

1. Bergamini TM: Vascular prostheses infection caused by bacterial biofilms. Semin Vasc Surg 3: 101-109, 1990.
2. Bandyk DF, Berni GA, Thiele BL, Towne JB: Aortofemoral graft infection due to Staphylococcus epidermidis. Arch Surg 119: 102-108, 1984.
3. Goldstone J, Moore WS: Infection in vascular prostheses; clinical manifestations and surgical management. Am J Surg 128: 225-233, 1974.
4. Edwards MJ, Richardson JD, Klamer TW: Management of aortic prosthetic infections. Am J Surg 155: 327-330, 1988.
5. Fry WJ: Vascular prosthetic infections. Surg Clin North Am 52: 1419-1424, 1972.
6. Bouhoutsos J, Chavatzos D, Martin P, et al: Infected synthetic arterial grafts. Br J Surg 61: 108-111, 1974.
7. Liekweg WG, Greenfield LJ: Vascular prosthetic infections: collected experience and results of treatment. Surgery 81: 335-342, 1977.
8. Bunt TJ: Synthetic vascular graft infections. Surgery 93: 733-746, 1983.
9. Greco RS: Utilizing vascular prosthesis for drug delivery. J Vasc Surg 5: 753-755, 1991.
10. Bandyk DF: Vascular graft infections: epidemiology, bacteriology and pathogenesis, in Bernhard VM, Towne JB (eds), Complications in Vascular Surgery, 2nd ed, Orlando, Grune and Stratton, Inc., 1985, pp. 471-485.
11. Schmitt DD, Bandyk DF, Peguet AJ, Malangoni MA, Towne JB: Production of Staphylococcus epidermidis: a virulent factor promoting adherence to vascular grafts. Arch Surg 121: 89-95, 1986.
12. Bergamini TM, Bandyk DF, Govostis D, Kaebnick HA, Towne JB: Infection of vascular prosthetics caused by bacterial biofilms. J Vasc Surg 7: 21-30, 1988.
13. Anwar H, Strap J, Costerton J: Establishment of aging biofilms: possible mechanism of bacterial resistance to antimicrobial therapy. Antimicrob Agents Chemother 36: 1347-1351, 1992.
14. Calligaro KD, Keith FJ, Gupta SR, et al: A modified method for management of prosthetic graft infections involving an anastomosis to the common femoral artery. J Vasc Surg 11: 485-492, 1990.
15. Jacobs MJ, Reul CJ, Gregoric I, Cooley DA: In situ replacement and extra-anatomic bypass for the treatment of infected abdominal aortic grafts. Eur J Vasc Surg 5: 83-86, 1991.
16. Bandyk DF, Bergamini TM, Kinney EJ, Seabrook GR, Towne JB: In situ replacement of vascular prostheses infected by bacterial biofilms. J Vasc Surg 13: 575-583, 1991.
17. Chervu A, Moore WS, Gelabert HA, Colburn MD, Chvapil M: Prevention of graft infection by use of prosthesis bonded with a rifampin/collagen release system. J Vasc Surg 14: 521-525, 1991.
18. Strachan CJL, Newsom SWB, Ashton TR: The clinical use of an antibiotic-bonded graft. Eur J Vasc Surg 5: 627-632, 1991.
19. Harvey RA, Greco RS: The noncovalent bonding of antibiotic to a polytetrafluoroethylene graft. Ann Surg 194: 642-647, 1981.
20. Greco RS, Harvey RA: The role of antibiotic bonding in the prevention of vascular prosthetic infections. Ann Surg 195: 168-171, 1980.
21. Goeau-Brissonniere O, Mercier F, Nicolas MH, et al: Treatment of vascular graft infection by in situ replacement with rifampin-bonded gelatin-scaled Dacron graft. J Vasc Surg 19: 739-744, 1994.
22. Powell TW, Burnham SJ, Johnson G: A passive system using rifampin to create an infection-resistant vascular prosthesis. Surgery 94: 765-769, 1983.
23. Cherry A, Moore WS, Chrapil M, Henderson T: Efficacy and duration of anti-Staphylococcal activity comparing three antibiotics bonded to Dacron vascular grafts with a collagen release system. J Vasc Surg 13: 897-901, 1991.
24. Farr B, Mandell GL: Rifampin. Med Clin North Am 66: 157-168, 1982.
25. Kunin CM, Brandt D, Wood H: Bacteriologic studies of rifampin, a new semisynthetic antibiotic. J Infect Dis 119: 132-138, 1969.
26. Bergamini TM, McCurry TM, Bernard JD, et al: Antibiotic efficacy against Staphylococcus epidermidis adherent to vascular grafts. J Surg Res 60: 1-4, 1996.
27. Lachapelle K, Graham AM, Symes JF: Antibacterial activity, antibiotic retention, and infection resistance of a rifampin-impregnated gelatin-sealed Dacron graft. J Vasc Surg 19: 675-682, 1994.
28. Wehrli W: Rifampin: mechanism of action and resistance. Infect Dis 5: S407-S411, 1983.
29. Dixson S, Branfill W, Hamilton-Miller JMT: Activity of rifampin against Staphylococci with special reference to multi resistant strains. J Antimicrob Chemother 13: 7-16, 1984.
30. Glen R: Vancomycin, in Gorbach SL, Bartlett JG, Blacklow NR (eds), Infectious Diseases, Philadelphia, WB Saunders, 1992, pp. 231-237.
31. Gagnon R, Richards G, Wisenfeld B: Staphylococcus epidermidis biofilms: unexpected outcome of double and triple antibiotic combinations with rifampin. ASAIO Trans 37: M158-M160, 1991.
32. Bandyk D, Bergamini T: Infection in prosthetic vascular grafts, in Rutherford R (ed), Vascular Surgery, 4th ed, Philadelphia, WB Saunders, 1994, pp. 588-603.
33. Obst G, Gagnon RF, Prentis J, Richards GR: Rifampin activity against Staphylococcus epidermidis biofilms. ASAIO Trans 34: 782-784, 1988.